64Cu-Labeled polyethyleneimine-coated manganese oxide nanoparticles for targeted tumor PET/MR imagin

来源 :2016年磁共振技术暨纳米生物医学应用研讨会 | 被引量 : 0次 | 上传用户:fz594825946
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objectives: The unique properties of Mn3O4 nanoparticles(NPs)provide a great opportunity for developing PET/MR imaging probes.In this study,we developed multifunctional polyethyleneimine(PEI)-coated Mn3O4 NPs and radiolabel the NPs with 64Cu for folate receptor(FR)-targeted dual-mode PET/MR imaging in mice bearing human cervical cancer xenografts.Methods: A solvothermal route was used to create PEI-coated Mn3O4 NPs by decomposition of acetylacetone manganese in the presence of PEI.Fluorescein isothiocyanate(FI),PEGylated folic acid(FA),and NOTA chelator were conjugated on the surface of PEI,and followed by acetylation of the remaining amines.The resulting NOTA-Mn3O4-PEI-Ac-FI-(PEG-FA)NPs were characterized,and the cytotoxicity of NPs was evaluated by MTT cell viability assay.The specific binding of NPs with HeLa cells overexpressing FR was confirmed by flow cytometry and confocal microscopy.The NOTA-Mn3O4-PEI-Ac-FI-(PEG-FA)NPs were then radiolabeled with 64Cu and subjected to small animal PET/MR imaging,and biodistribution studies.The FR binding specificity of NPs was further evaluated by in vivo blocking studies.Results: Multifunctional FR-targeted Mn3O4 NPs were successfully synthesized,and radiolabeled with 64Cu in >85%decay-corrected yield with radiochemical purity of >99%.The MTT assay showed that NOTA-Mn3O4-PEI-Ac-FI-(PEG-FA)NPs are non-cytotoxic at the concentration up to 100 μg/mL.The FA modification renders the NPs with targeting specificity to cancer cells overexpressing FR,which is confirmed by flow cytometry and confocal microscopy studies.MicroPET imaging results showed that 64Cu-labeled Mn3O4 NPs exhibit excellent tumor uptake in FR-positive HeLa tumor xenografts(T/M ratio: 6.03 ± 2.35 at 18 h pi)via FR-mediated active targeting pathway,and significantly lower tumor uptake in the FR-blocking group(T/M ratio: 2.78 ± 0.68 at 18 h pi).Tumor binding specificity was also confirmed by ex vivo PET imaging and biodistribution studies.In addition,FR-targeted Mn3O4 NPs enabled efficient T1-weighted MR imaging,and the excellent tumor MR imaging was achieved at 18 h pi.Conclusions: The 64Cu-labeled multifunctional Mn3O4 NPs have been successfully developed for PET/MR imaging of FR overexpression.PET/MRI with 64Cu-NOTA-Mn3O4-PEI-Ac-FI-(PEG-FA)NPs may provide a unique approach to quantitatively localize and characterize FR-expressing tumors.
其他文献
Gd-doped MnCO3 nanoparticles(NPs)have been prepared by thermal decomposition of Mn-oleate with 20 mol%Gd-oleate at 310 ℃.However,MnCO3 tends to transform to MnO at temperature above 300 ℃.Developing t
癌症目前已经成为严重危害人类健康的疾病之一.尽管经过研究人员不断开发,目前已经有几十种药物投入临床化疗,然而癌症治疗的效果仍然远远低于预期1.例如三氧化二砷作为传统化疗药物,主要有治疗急性早幼粒细胞白血病的功效2,但治疗实体瘤的效果不是很理想.顺铂虽然是最广泛使用的治疗实体瘤的化疗药物,但容易使癌细胞产生抗药性.随着新世纪纳米科学技术的发展,可用于装载小分子化疗药物的纳米载体即纳米药物这一概念应运
磁共振成像(MRI)具有无电离辐射,无组织穿透深度限制和良好空间分辨率等优点,临床上约有临床上约有35%-40%的病变都需要使用造影剂来获得准确的病灶信息.造影剂又可以分为T1造影剂和T2造影剂.T1造影剂是利用水中氢质子与顺磁性金属离子直接作用来缩短弛豫时间,从而增强信号,使图像变亮;T2造影剂是通过外部磁场的局部不均匀性进行干扰,使邻近氢质子的弛豫中很快产生相来缩短弛豫时间,从而减弱信号,使图
目前临床使用的磁共振造影剂普遍存在弛豫率较低,灵敏度有待提高的问题,发展高效的造影剂对组织的精确诊断具有重要意义[1]。作为领域中研究使用最广泛的造影剂,磁性氧化铁纳米的晶体结构与造影性能关系的研究仍很初步,如何有效提高造影性能仍亟需深入发展。我们以氧化铁纳米结构为基础,以金属掺杂的策略,研究了氧化铁纳米晶体结构与造影性能的构效关系[2]。通过钆金属掺杂,得到一种高性能的T1明场磁共振造影剂[3]
磁共振成像作为一种高效、无害的检测手段,在医疗诊断方面已得到了广泛的应用。磁共振造影剂能缩短组织在外磁场作用下的弛豫时间、增大对比信号的差异、提高成像对比度和清晰度。氧化铁纳米颗粒易合成放大,而且有较好的生物相容性和较低的毒性,是一类广泛应用的磁共振造影剂。本课题利用高温热分解法,通过对实验条件的改进和优化,得到了不同尺寸和形貌的氧化铁纳米颗粒。实验结果表明,氧化铁纳米颗粒的造影行为具有尺寸依赖性
热物理治疗是肿瘤治疗的重要手段,治疗过程中的加热温度及空间区域的精确控制对实现最佳治疗效果及减小副作用至关重要.磁共振成像(MRI)具有不受组织穿透深度限制,无电离辐射,良好空间分辨率等优点,并且人体内温度变化能引起组织信号的多参数变化,因而成为发展无创体内温度监控技术最有效的途径.[1]目前的体内温度监控MRI方法主要基于1H的MRI参数温度依赖性,其各有优缺点,尚不能完全满足临床需要.19F在
Magnetic resonance(MR)imaging is an important medical diagnostic technique widely used in modern medicine for cancer diagnosis,due to its noninvasive,high spatial resolution,and nonionizing radiation
用于生物医学的多功能性纳米平台的设计和发展得到了人们的极大关注。在此,我们报告了有机相合成的四氧化三锰纳米颗粒以及它们的杂化材料在肿瘤的核磁共振(MR)成像方面的最新研究进展。通过溶剂热法制备的具有良好的水相分散性和胶体稳定性的四氧化三锰纳米颗粒将会被介绍。同时,一些关键的技术用于提高四氧化三锰纳米颗粒的磁豫率(r1),延长血液循环时间以及减少纳米颗粒的巨噬细胞吞噬将会被详细地讨论。另外,有机相合
发展新型的T1纳米造影剂用于增强的磁共振(magnetic resonance,MR)成像是当前纳米医学与影像诊断学的新动向。本文研究了功能化的、同时负载了两种T1造影元素的纳米造影剂的制备及其T1-T1协同增强效应。在一步溶剂热法制备的聚乙烯亚胺(PEI)包裹的Mn3O4纳米颗粒外围,修饰Gd 离子螯合剂并螯合Gd离子,随后对其进行聚乙二醇化和靶向试剂修饰。采用多种方法对其进行了表征,并用于MR
会议